Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery
POPI
Randomized Trial of Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device After Vaginal Delivery
1 other identifier
interventional
168
1 country
1
Brief Summary
This study is a randomized controlled trial comparing 6 month usage rates of the levonorgestrel-releasing intrauterine device (LNG-IUD) when inserted postplacentally after vaginal delivery or delayed placement at 6-8 weeks postpartum. Given the high rate of unintended pregnancy in the United States, particularly in postpartum women, there is a need for reliable, effective, long-term contraception such as the IUD in postpartum women. Postplacental insertion of intrauterine contraception would help to address this need. The primary hypothesis of this study is that use of the LNG-IUD at 6 months after vaginal delivery will be higher in women who have immediate postplacental insertion as compared to delayed insertion 6-8 weeks following delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 17, 2007
CompletedFirst Posted
Study publicly available on registry
May 21, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedResults Posted
Study results publicly available
February 19, 2016
CompletedJune 24, 2016
May 1, 2016
1.4 years
May 17, 2007
December 1, 2014
May 17, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IUD Usage Rate at 6 Months
Usage rate of the LNG-IUD at 6 months after delivery
6 months after delivery
Secondary Outcomes (5)
Proportion of Women Who Are Able to Have the LNG-IUD Placed Postplacentally and Are Not Excluded From Placement
6 months
Follow-up Rates for Delayed Insertion of LNG-IUD
6 months
Expulsion Rates of Post-placental and Delayed Insertion of the LNG-IUD Using Clinical Exam and Ultrasonography
6 months
Safety of Postplacental Insertion of the LNG-IUD as Measured by Infection Rates
6 months
Rates of Follow-up and Unintended Pregnancy Rates for Subjects Who Are Excluded From Postpartum Insertion
6 months
Study Arms (2)
Postplacental IUD insertion
EXPERIMENTALimmediate postplacental levonorgestrel-releasing IUD (Mirena) insertion
Delayed IUD insertion
ACTIVE COMPARATORdelayed levonorgestrel-releasing IUD (Mirena) insertion (6-8 weeks after delivery)
Interventions
levonorgestrel-releasing IUD containing 52 mg levonorgestrel, indicated for use for up to 5 years
Eligibility Criteria
You may qualify if:
- Age greater than or equal to 18 years
- Greater than or equal to 24 0/7 weeks pregnant at time of enrollment
- Anticipates undergoing a vaginal delivery
- Desires to use the LNG-IUD (Mirena) for postpartum contraception
- Willing and able to sign an informed consent in English
- Willing to comply with the study protocol
You may not qualify if:
- Planning to undergo a scheduled cesarean section
- Allergy to either polyethylene or levonorgestrel or other contraindications to use of the LNG-IUD
- Exposure to or treatment for gonorrhea, chlamydia, or trichomoniasis during the pregnancy
- Presence of one or more leiomyomata greater than 3 centimeters in diameter
- Uterine anomaly (other than a repaired septate uterus)
- Current cervical cancer or carcinoma in-situ
- Desires repeat pregnancy within one year of delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Magee-Womens Hospital, University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (2)
Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2010 Nov;116(5):1079-87. doi: 10.1097/AOG.0b013e3181f73fac.
PMID: 20966692RESULTChen BA, Reeves MF, Creinin MD, Schwarz EB. Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration. Contraception. 2011 Nov;84(5):499-504. doi: 10.1016/j.contraception.2011.01.022. Epub 2011 Apr 16.
PMID: 22018124RESULT
Related Links
Results Point of Contact
- Title
- Principal Investigator
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Beatrice A Chen, MD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 17, 2007
First Posted
May 21, 2007
Study Start
May 1, 2007
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
June 24, 2016
Results First Posted
February 19, 2016
Record last verified: 2016-05